The phrase "assays the data from" is correct and usable in written English.
It can be used in contexts where you are discussing the analysis or examination of data sourced from a particular origin or study.
Example: "The researcher assays the data from the latest clinical trial to determine the effectiveness of the new drug."
Alternatives: "analyzes the data from" or "examines the data from".
In this assay, the data from fluorescence spectrophotometer displayed a dose-dependent manner of CHIR99021, with the EC50 of around 206 nM, and the maximum effective concentration was 1 µM (Fig. 3g, 3i).
Furthermore, the long-term clonogenic survival assay supported the data from the short-term cell survival CCK-8 assay, indicating that overexpression of XRCC1 enhanced the survival of BGC823 cells, while knockdown of XRCC1 in BGC823/DDP cells decreased their survival in response to cisplatin.
If the Q-RT-PCR reactions failed in 50% of the assays, the data were excluded from further statistical analysis.
Design of targeted amplicon sequencing assays and analysis of the data from these assays requires awareness of the variant calling blind spots near the ends of a read.
To conduct a more powerful test of the similar trends we found in the two longevity assays we combined the data from the two assays (but excluded the intermediately inbred genotypes that only was present in assay I), and treated the two assays as independent blocks.
As an alternative way of presenting the data, we also show in the Supplementary figures the individual data points for each donor, adjusted to account for day-to-day variation in assay performance by normalizing the data from each sample to the mean of the control (HbAAαα/αα) cells run on the same day.
Collectively, these data indicate that the phenotypes identified using the Fitness Assay mostly overlap with the data from Kamath et al. 2003 [ 1] and that overall if we were to re-perform a genome-wide screen, we would miss some, but also detect a few new ones.
For many studies involving biomarker assay, an IDE is not required because the data from biomarker assay studies can be compared to a gold standard method which is used for patient care.
Each value is the mean of the data from assays performed in duplicate.
However, with all the limitations due to the small sample size and to the lack of a specific assay in vitro assay, we can speculate, according to the data from Ko et al. [ 17], that the presence of the TET2 mutation can induce a second clone with a prominent monocytic differentiation.
